Obesity

New weight loss pill outperforms Wegovy in early trials

Novo Nordisk's new obesity pill, amycretin, has shown promising results in early clinical trials, with participants losing up to 13% of their body weight in just 12 weeks, significantly outperforming placebo groups. The treatment may offer faster weight loss than Novo's popular Wegovy injection.

Forbes

Sudden unexpected infant death (SUID) risk may be linked to maternal obesity

Paternal consumption of fish oil may reduce obesity risk in offspring

Clarivate announces 2023 Journal Impact Factors

Clarivate, owner of Web of Science, the citation index of scientific and scholarly publishing, has published its 2023 Journal Impact Factors as part of its 2024 Journal Citation Reports. We are delighted to announce significant increases in Journal Impact Factors for Reproduction and Fertility and EFORT Open Reviews. Reproduction and Fertility, an official journal of the Society for Reproduction and Fertility (SRF) has achieved a 2023 figure of 2.8.

Weight loss and metabolic outcomes improve with intermittent fasting and protein pacing diet

People with obesity using semaglutide see cardiovascular improvements

Men with obesity lose more weight with cash incentives, research says

People with obesity and high weight linked to feeling increased pain intensity

Study suggests effectiveness of apple cider vinegar (ACV) in reducing obesity risk